Becton Dickinson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Becton Dickinson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BDX

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. 

CEO
Thomas E. Polen
CEOThomas E. Polen
Employees
72,000
Employees72,000
Headquarters
Franklin Lakes, New Jersey
HeadquartersFranklin Lakes, New Jersey
Founded
1897
Founded1897
Employees
72,000
Employees72,000

BDX Key Statistics

Market cap
42.12B
Market cap42.12B
Price-Earnings ratio
38.37
Price-Earnings ratio38.37
Dividend yield
2.77%
Dividend yield2.77%
Average volume
3.94M
Average volume3.94M
High today
High today
Low today
Low today
Open price
$151.94
Open price$151.94
Volume
0.00
Volume0.00
52 Week high
$187.35
52 Week high$187.35
52 Week low
$129.03
52 Week low$129.03

Stock Snapshot

Becton Dickinson(BDX) stock is priced at $152.90, giving the company a market capitalization of 42.12B. It carries a P/E multiple of 38.37 and pays a dividend yield of 2.77%.

During the trading day, Becton Dickinson(BDX) stock saw an opening price of $151.94, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 3.94M.

Over the past 52 weeks, Becton Dickinson(BDX) stock has traded between a high of $187.35 and a low of $129.03.

Over the past 52 weeks, Becton Dickinson(BDX) stock has traded between a high of $187.35 and a low of $129.03.

BDX News

Simply Wall St 1d
Becton Dickinson Wins Vizient Contract As Fair Value Stays In Focus

Advertisement Why Becton Dickinson is back on investors’ radar Becton Dickinson (BDX) is drawing fresh attention after its BD CentroVena One Insertion System...

Becton Dickinson Wins Vizient Contract As Fair Value Stays In Focus
Simply Wall St 4d
Is Vizient’s Nod to BD CentroVena One Quietly Reframing Becton Dickinson’s Competitive Moat?

Earlier this month, Becton, Dickinson and Company announced that its BD CentroVena One Insertion System received an Innovative Technology contract from Vizient,...

Is Vizient’s Nod to BD CentroVena One Quietly Reframing Becton Dickinson’s Competitive Moat?

Analyst ratings

59%

of 17 ratings
Buy
41.2%
Hold
58.8%
Sell
0%

People also own

Based on the portfolios of people who own BDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.